Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial [ 2015 - ]

Research Grant

Researchers: Prof Mark Parsons (Principal investigator) ,  A/Pr Bruce Campbell ,  Prof Christopher Levi ,  Prof Gregory Albers ,  Prof Hugh Markus
View all 13 related researchers

Brief description Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) is an Australian-led international randomised trial designed to generate practice-changing evidence by translating the advanced imaging treatment selection approach used in our previous pilot studies. TASTE aims to confirm the superiority of the new-generation clot-dissolving agent, tenecteplase, over the standard agent, alteplase, in the broad group of stroke patients eligible for acute clot-dissolving treatment.

Funding Amount $3,989,898.00

Funding Scheme Project Grants

Notes Standard Project Grant